Interestingly, our KEGG pathway analysis identifies that, for all time points, sonidegib treatment affects the regulation of the “basal cell carcinoma” pathway (which involves the differential expression of both Shh and Ptch; S12 Fig). This evidence concerns the gene PTCH1 and basal cell carcinoma.